Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma

Immunomodulatory drugs (IMiDs) are effective therapeutics for multiple myeloma (MM), where in different clinical settings they exert their function both directly on MM cells and indirectly by modulating immune cell subsets, although with not completely defined mechanisms. Here we studied the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lullo, Giulia, Marcatti, Magda, Heltai, Silvia, Tresoldi, Cristina, Paganoni, Anna Maria, Bordignon, Claudio, Ciceri, Fabio, Protti, Maria Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348257/
https://www.ncbi.nlm.nih.gov/pubmed/30719025
http://dx.doi.org/10.3389/fimmu.2018.03171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348257/
https://www.ncbi.nlm.nih.gov/pubmed/30719025
http://dx.doi.org/10.3389/fimmu.2018.03171

Ejemplares similares